SEC Form 4 · accession 0001144204-18-050779
TITAN PHARMACEUTICALS INC · TTNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Marc Rubin
Officer — Executive Chairman · Director
Period of report
Sep 21, 2018
Accepted (ET)
Sep 25, 2018 · 7:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000910267
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 21, 2018 | P | 400,000 | $0.25 | A | 556,317 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrants | $0.25 | Sep 21, 2018 | A | 400,000 | A | Sep 25, 2018 | Sep 25, 2023 | common stock | 400,000 | 400,000 | D |